기업공개 보도자료
-
- SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements
- Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the “Notification Letter”), from Hearing Adviso...
- 06월 16일 08:55
